Suppr超能文献

新型抗肿瘤(氯甲基)呋喃吲哚啉的全合成及生物学性质:烷基化亚基的不对称硼氢化介导合成

Total synthesis and biological properties of novel antineoplastic (chloromethyl)furanoindolines: an asymmetric hydroboration mediated synthesis of the alkylation subunits.

作者信息

Mohamadi F, Spees M M, Staten G S, Marder P, Kipka J K, Johnson D A, Boger D L, Zarrinmayeh H

机构信息

Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana 46285.

出版信息

J Med Chem. 1994 Jan 21;37(2):232-9. doi: 10.1021/jm00028a005.

Abstract

1,2-Dihydro-1-(chloromethyl)-5-hydroxy-8-methyl-3H-furano[3,2-e]in dole (CFI) as a novel replacement of the cyclopropylpyrroloindoline (CPI) alkylation subunit of CC-1065, U-71184, and U-73975 (adozelesin) has been synthesized and incorporated into a series of efficacious antineoplastic agents. A partial solution to an asymmetric synthesis of the CFI alkylation subunit has been achieved by the implementation of an asymmetric hydroboration reaction of an intermediate 3-methyleneindoline (13). Extension to the asymmetric synthesis of the CBI and CI alkylation subunits is presented. The demonstration and comparative study of the sequence-selective DNA alkylation properties of the CFI-based agents are detailed, and the preliminary in vitro and in vivo antineoplastic properties of these agents in the human epidermoid cell lung carcinoma (T222) are described.

摘要

1,2-二氢-1-(氯甲基)-5-羟基-8-甲基-3H-呋喃并[3,2-e]吲哚(CFI)作为CC-1065、U-71184和U-73975(阿多来新)中环丙基吡咯并吲哚(CPI)烷基化亚基的新型替代物已被合成,并被纳入一系列有效的抗肿瘤药物中。通过对中间体3-亚甲基吲哚(13)进行不对称硼氢化反应,实现了CFI烷基化亚基不对称合成的部分解决方案。本文介绍了将其扩展到CBI和CI烷基化亚基的不对称合成。详细阐述了基于CFI的药物对序列选择性DNA烷基化性质的论证和比较研究,并描述了这些药物在人表皮样肺癌细胞(T222)中的初步体外和体内抗肿瘤性质。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验